Treatment of Urinary Tract Infections Based on Urinalysis Results
For uncomplicated UTIs in women, first-line treatment options include nitrofurantoin 100mg twice daily for 5 days, fosfomycin 3g single dose, or trimethoprim-sulfamethoxazole 160/800mg twice daily for 3 days, with selection based on local resistance patterns. 1, 2, 3
Diagnostic Approach
- In women with typical symptoms (dysuria, frequency, urgency, nocturia, suprapubic pain) without vaginal discharge, clinical diagnosis is often sufficient 3
- Urine culture is recommended in specific situations:
- Suspected acute pyelonephritis
- Symptoms that don't resolve or recur within 4 weeks after treatment
- Women with atypical symptoms
- Pregnant women 1
Treatment Algorithm for Uncomplicated UTIs
First-line options for non-pregnant women:
- Nitrofurantoin 100mg twice daily for 5 days (high evidence level) 2, 3
- Fosfomycin trometamol 3g single dose 1, 2
- Trimethoprim-sulfamethoxazole 160/800mg twice daily for 3 days (if local resistance <20%) 1, 2, 4
- Pivmecillinam 400mg three times daily for 3-5 days 1, 2
For men with UTI:
- Trimethoprim-sulfamethoxazole 160/800mg twice daily for 7 days 1, 3
- Treatment duration should be longer (7 days) compared to women 3
For complicated UTIs/pyelonephritis:
- Ciprofloxacin 500mg twice daily for 7 days (if local fluoroquinolone resistance <10%) 2
- Ceftriaxone or cefotaxime for severe pyelonephritis 2
Special Populations
Pregnant women:
- Nitrofurantoin or Cephalexin as first-line treatments 2
- Avoid trimethoprim-sulfamethoxazole in first and third trimesters 2
Patients with renal impairment:
- For creatinine clearance >30 mL/min: standard regimen
- For creatinine clearance 15-30 mL/min: half the usual regimen
- For creatinine clearance <15 mL/min: not recommended 4
Management of Recurrent UTIs
- Defined as ≥3 UTIs per year or 2 UTIs in the last 6 months 1
- Risk factors include sexual intercourse, spermicide use, new sexual partner, maternal history of UTI, and childhood UTI history 1
- Preventive measures:
Common Pitfalls to Avoid
Treating asymptomatic bacteriuria: Should be avoided except in pregnant women and patients undergoing urological procedures 2
Overuse of fluoroquinolones: Reserve for complicated infections due to resistance concerns and side effects 2, 3
Inadequate follow-up: For women whose symptoms don't resolve by end of treatment or recur within 2 weeks, obtain urine culture and susceptibility testing 1
Failure to consider local resistance patterns: Local antibiotic resistance should guide empiric therapy choices 1, 2
Not changing indwelling catheters before culture: When collecting samples from catheterized patients, change the catheter first 2
By following these evidence-based recommendations, clinicians can effectively treat UTIs while minimizing antibiotic resistance and optimizing patient outcomes.